Official opening of Almac Diagnostic Services headquarters
July 9, 2009
‘Marty Murphy’ building opened by eminent cancer specialist
The headquarters of Almac Diagnostic Services, a division of the Almac Group, was officially opened today by renowned oncologist Dr Martin Murphy. Almac Diagnostic Services is based within the company’s headquarters in Craigavon, Northern Ireland with additional facilities in Durham, North Carolina. Almac Chairman Sir Allen McClay has hailed today’s opening as a ‘significant step forward for Almac.’
Alongside Dr Murphy, other guests included Upper Bann MP David Simpson, Meta Crozier the Mayor of Craigavon, Managing Director of Clients & Entrepreneurship Group for Invest NI, Ian Murphy and other business representatives.
Welcoming the guests Group Chairman Sir Allen McClay said: “This is a milestone day for Almac which cements our position as a world leading pharmaceutical and biotech service company. The Diagnostics Services division develops and delivers genomic solutions for the advancement of science and the improvement of patient care. From our base here in Northern Ireland we are making a major contribution in particular to cancer research. We have a strong relationship with Dr Martin Murphy who has been a friend to Almac since we were founded. It is an honour and a pleasure to have this building dedicated to Dr Murphy and to host him and his family today.”
Dr Murphy said: “The fight against cancer is an international crusade which is led by talented, energetic and committed people and organisations. One of those organisations is Almac and I am honoured to have worked with the people behind this organisation for a number of years. The people of Northern Ireland really should be proud of the work which goes on at this site. It is no exaggeration to say that thanks to those working at Almac, Northern Ireland is now at the forefront of cancer research. I want to thank Sir Allen McClay, Professor Paddy Johnston and all of their colleagues for their support and I am proud to open the Marty Murphy building.”
T: +44(0)2890 339949
Notes to Editors
About Dr Martin Murphy:
Dr Murphy is the Founding Executive Editor of the thirteen-year-old international, peer-reviewed journal, The Oncologist. He is a member of the International Board of Advisors of the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, a member of the Queen’s University-Belfast Medical School International Review Panel, director of the Foundation for the National Institutes of Health, the American Society of Clinical Oncology Foundation, a co-founder of the All-Ireland Cancer Foundation, and a charter member of C-Change co-chaired by former President George Bush and former First Lady Barbara Bush
About Almac Diagnostic Services:
Almac Diagnostic Services is a personalised medicine company whose core expertise is in the provision of genomic-based solutions. Almac utilise their experience, expertise and unique Cancer DSA™ technology to partner with customers enabling translational genomic solutions for personalised medicine. Current developments include a pipeline of genomics based IVD tests, all of which have been developed from FFPE tissue.
Almac Diagnostic Services has received support from Invest NI and the European Regional Development Programme.
About Almac Group:
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS and Web), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.
The company employs over 2,400 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $112m North American Headquarters started in July 08 and is expected to be completed 2010. Almac was awarded Northern Ireland’s “Business of the Year” award in 2009.